Clinical Trial Update: A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC [Phase 1]

View source ↗

Summary

Phase 1 trial of novel anti-cancer agents in patients with metastatic non-small cell lung cancer; the study is active but not currently recruiting, sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Metastatic Non-Small Cell Lung Cancer (NSCLC) | Phase 1 | Status: ACTIVE_NOT_RECRUITING